Eigsti Renee L, Krasowski Matthew D, Vidholia Aditi, Merrill Anna E
Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, USA.
Data Brief. 2020 Mar 10;30:105408. doi: 10.1016/j.dib.2020.105408. eCollection 2020 Jun.
Clinical chemistry analysis of body fluids from non-blood or urine sources presents a technical challenge for clinical laboratories. Examples of body fluids include biliary secretions, cerebrospinal fluid, cyst contents, dialysate, gastric aspirates, peritoneal fluid, pleural fluid, stool, surgical drain fluid, synovial fluid, and wound exudates. The heterogeneous nature of these body fluids presents technical difficulties for analysis. For example, body fluid specimens may have presence of hemolysis, icterus, or lipemia ('interference indices') that can interfere with clinical chemistry analysis. In the related research article, we analyzed the distribution of these interference indices and body fluid samples submitted for analysis at an academic medical center central clinical laboratory and compared this to data from serum/plasma specimens. The data in this article provide the body fluid type, clinical chemistry testing ordered, interference indices, and whether the indices exceeded the manufacturer's recommendations in the package insert for serum/blood specimens. The analyzed data are provided in the supplementary tables included in this article. The dataset reported is related to the research article entitled "Review of interference indices in body fluids specimens admitted for clinical chemistry analyses" [1].
对非血液或尿液来源的体液进行临床化学分析,对临床实验室来说是一项技术挑战。体液的例子包括胆汁分泌液、脑脊液、囊肿内容物、透析液、胃吸出物、腹腔液、胸腔液、粪便、手术引流液、滑液和伤口渗出液。这些体液的异质性给分析带来了技术难题。例如,体液标本可能存在溶血、黄疸或脂血(“干扰指标”),会干扰临床化学分析。在相关研究文章中,我们分析了一家学术医疗中心中央临床实验室提交进行分析的这些干扰指标和体液样本的分布情况,并将其与血清/血浆标本的数据进行了比较。本文中的数据提供了体液类型、所开的临床化学检测项目、干扰指标,以及这些指标是否超过了血清/血液标本包装说明书中制造商的建议。分析数据列于本文附带的补充表格中。报告的数据集与题为《临床化学分析所收体液标本干扰指标综述》的研究文章相关[1]。